OBJECTIVE: Neovascularization is a physiologic repair process that partly depends on nitric oxide. Extracellular superoxide dismutase (EcSOD) is the major scavenger of superoxide. It is an important regulator of nitric oxide bioavailability and thus protects against vascular dysfunction. We hypothesized that overexpression of EcSOD in skeletal muscle would improve recovery from hind-limb ischemia. METHODS: Adeno-associated virus serotype 9 (AAV9) vectors expressing EcSOD or luciferase (control) from the cytomegalovirus promoter were cross-packaged into AAV9 capsids and injected intramuscularly into the hind-limb muscles (1 × 10(11) viral genomes/limb) of 12-week-old mice. Ischemia was induced after intramuscular injections. Laser Doppler was used to measure limb perfusion on days 0, 7, and 14 after injection. Values were expressed as a ratio relative to the nonischemic limb. EcSOD expression was measured by Western blotting. Capillary density was documented by immunohistochemical staining for platelet endothelial cell adhesion molecule. Apoptosis was assessed by terminal deoxynucleotide transferase-mediated biotin-deoxy uridine triphosphate nick-end labeling and necrosis was visually evaluated daily. RESULTS: EcSOD expression was twofold upregulated in EcSOD treated vs control ischemic muscles at day 14. Capillary density (capillaries/fiber) was 1.9-fold higher in treated (1.65 ± 0.02) vs control muscle (0.78 ± 0.17, P < .05). Recovery of perfusion ratio at day 14 after ischemia was 1.5-fold greater in EcSOD vs control mice (P < .05). The percentage of apoptotic nuclei was 1.3% ± 0.4% in EcSOD-treated mice compared with 4.2% ± 0.2% in controls (P < .001). Limb necrosis was also significantly lower in EcSOD vs control mice. CONCLUSION: AAV9-mediated overexpression of EcSOD in skeletal muscle significantly improves recovery from hind-limb ischemia in mice, consistent with improved capillary density and perfusion ratios in treated mice.
OBJECTIVE: Neovascularization is a physiologic repair process that partly depends on nitric oxide. Extracellular superoxide dismutase (EcSOD) is the major scavenger of superoxide. It is an important regulator of nitric oxide bioavailability and thus protects against vascular dysfunction. We hypothesized that overexpression of EcSOD in skeletal muscle would improve recovery from hind-limb ischemia. METHODS:Adeno-associated virus serotype 9 (AAV9) vectors expressing EcSOD or luciferase (control) from the cytomegalovirus promoter were cross-packaged into AAV9 capsids and injected intramuscularly into the hind-limb muscles (1 × 10(11) viral genomes/limb) of 12-week-old mice. Ischemia was induced after intramuscular injections. Laser Doppler was used to measure limb perfusion on days 0, 7, and 14 after injection. Values were expressed as a ratio relative to the nonischemic limb. EcSOD expression was measured by Western blotting. Capillary density was documented by immunohistochemical staining for platelet endothelial cell adhesion molecule. Apoptosis was assessed by terminal deoxynucleotide transferase-mediated biotin-deoxy uridine triphosphate nick-end labeling and necrosis was visually evaluated daily. RESULTS:EcSOD expression was twofold upregulated in EcSOD treated vs control ischemic muscles at day 14. Capillary density (capillaries/fiber) was 1.9-fold higher in treated (1.65 ± 0.02) vs control muscle (0.78 ± 0.17, P < .05). Recovery of perfusion ratio at day 14 after ischemia was 1.5-fold greater in EcSOD vs control mice (P < .05). The percentage of apoptotic nuclei was 1.3% ± 0.4% in EcSOD-treated mice compared with 4.2% ± 0.2% in controls (P < .001). Limb necrosis was also significantly lower in EcSOD vs control mice. CONCLUSION: AAV9-mediated overexpression of EcSOD in skeletal muscle significantly improves recovery from hind-limb ischemia in mice, consistent with improved capillary density and perfusion ratios in treated mice.
Authors: Konkal-Matt R Prasad; Yaqin Xu; Zequan Yang; Marie-Claire Toufektsian; Stuart S Berr; Brent A French Journal: Mol Ther Date: 2007-02-13 Impact factor: 11.454
Authors: Ayotunde O Dokun; Sehoon Keum; Surovi Hazarika; Yongjun Li; Gregory M Lamonte; Ferrin Wheeler; Douglas A Marchuk; Brian H Annex Journal: Circulation Date: 2008-02-19 Impact factor: 29.690
Authors: Roger J Hajjar; Krisztina Zsebo; Lawrence Deckelbaum; Craig Thompson; Jeff Rudy; Alex Yaroshinsky; Hung Ly; Yoshiaki Kawase; Kim Wagner; Kenneth Borow; Brian Jaski; Barry London; Barry Greenberg; Daniel F Pauly; Richard Patten; Randall Starling; Donna Mancini; Mariell Jessup Journal: J Card Fail Date: 2008-05-27 Impact factor: 5.712
Authors: Alexandra Aicher; Christopher Heeschen; Susanne Feil; Franz Hofmann; Michael E Mendelsohn; Robert Feil; Stefanie Dimmeler Journal: PLoS One Date: 2009-03-16 Impact factor: 3.240
Authors: Nabil E Boutagy; Silvia Ravera; Xenophon Papademetris; John A Onofrey; Zhen W Zhuang; Jing Wu; Attila Feher; Mitchel R Stacy; Brent A French; Brian H Annex; Nancy Carrasco; Albert J Sinusas Journal: Circ Cardiovasc Imaging Date: 2019-07-12 Impact factor: 7.792
Authors: Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér Journal: Physiol Rev Date: 2016-01 Impact factor: 37.312
Authors: Jarrod A Call; Kristopher H Chain; Kyle S Martin; Vitor A Lira; Mitsuharu Okutsu; Mei Zhang; Zhen Yan Journal: Circ Heart Fail Date: 2014-12-11 Impact factor: 8.790
Authors: Cassidy Delaney; Rachel H Wright; Jen-Ruey Tang; Crystal Woods; Leah Villegas; Laurie Sherlock; Rashmin C Savani; Steven H Abman; Eva Nozik-Grayck Journal: Pediatr Res Date: 2015-08-31 Impact factor: 3.756